FINEVISION HP Trifocal IOLs
Beaver-Visitec International, Inc. · Decision date Sep 25, 2026
What did the FDA approve?
The FDA database lists decision APPR dated 2026-09-25 for P240038/S003, a Real-Time Process supplement to the FINEVISION HP Trifocal intraocular lens PMA filed by Beaver Visitec International, Inc. The supplement reason is recorded as "Labeling Change - Indications/instructions/shelf life/tradename," and the recorded specialty is Ophthalmic under product code HQL. The supplement number establishes this as a change to the existing P240038 PMA rather than a new approval of the whole lens system.
The reported statement covers an extension of device shelf life from 3 years to 5 years and an expanded storage condition range to 2-35°C. Beyond those two labeling parameters, the supplied fields do not describe the original PMA scope, the prior storage range, or the evidence supporting the change, so the basis for the decision cannot be assessed from this record. The statement documents a reported purpose only and does not establish safety or clinical effectiveness.
FDA approval order statement
approval for an extension of the device shelf life from 3 years to 5 years, and expanded storage condition range to 2-35°C, for the FINEVISION HP Trifocal intraocular lens.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 25, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P240038/S003
- Regulatory pathway
- PMA supplement
- Applicant
- Beaver-Visitec International, Inc.
- Product code
- HQL
- Decision code
- APPR
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Beaver-Visitec International, Inc.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240038. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240038 · Original PMA
FINEVISION HP Trifocal IOLs
P240038/S003 received
Application receipt date recorded by FDA.
P240038/S003 · FDA decision
Real-Time Process
P240038/S004 · Related supplement
FINEVISION HP Trifocal IOLs
Timeline entries are records held by MedtechLedger for P240038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038 | Beaver-Visitec International, Inc. | PMA approval | Sep 10, 2025 | FDA |
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Beaver-Visitec International, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 500 Totten Pond Rd., Waltham, MA, 02451
Sources and methodology
- Original FDA record: P240038/S003
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





